How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Yahoo! Finance
on refreshed assumptions for how the business might grow and be financed over time. The model now uses a discount rate of 7.93% and a revenue growth rate of 18.48%, signalling that recent Street research is trying to balance higher growth expectations with a higher required return. As you read on, keep an eye on how these shifting inputs shape the story around Immunocore and how you can stay on top of future changes in this narrative. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Immunocore Holdings. ?? Bullish Takeaways UBS has shifted to a more positive stance on Immunocore, moving its rating to Buy from Sell and setting a price target of US$55, up from US$24. This points to a materially higher level of conviction in the story compared with its prior view. The UBS analyst groups Immunocore with a broader set of small to mid cap biotech names where they see improving fundamentals and expect investor confid
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Immunocore (NASDAQ:IMCR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Immunocore (NASDAQ:IMCR) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "strong-buy" rating.MarketBeat
- Immunocore (NASDAQ:IMCR) was given a new $55.00 price target on by analysts at UBS Group AG.MarketBeat
IMCR
Earnings
- 11/6/25 - Beat
IMCR
Sec Filings
- 1/9/26 - Form 8-K
- 12/8/25 - Form 4
- 12/1/25 - Form 4
- IMCR's page on the SEC website